Need Help? Call 1­-866-­796-­7386
« back to stock screener

  ALXN stock: Alexion Pharmaceuticals, Inc.

Current Rating
Sell

Previous Rating:

Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$119.54
Market Cap
27.42B
Sector
Health Care
Div. Growth
-
P/E
68.9
P/B
3.1
P/S
8.75
Dividend %
-
P/CF
-
P/FCF
36.5
Op. Cash Flow
1.09M
FCF
3.3
Op. Margin
21.60%
Net Margin
12.90%
ROE
4.80%
ROI
4.20%
ROA
3.00%
EPS Growth
127.70%
Current Ratio
3.1
Debt/Equity
33.20%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Oramed Pharmaceuticals, Inc. (ORMP) $6.93 - - 81.4M Strong Buy
Zynex Inc. (ZYXI) $0.31 - - 9.7M Strong Buy
InfuSystem Holdings Inc (INFU) $2.20 - - 51.1M Strong Buy
Daxor Corporation (DXR) $7.20 - 0.40% 28.3M Strong Buy
Merus Labs International Inc ( (MSLI) $0.76 - - 108.2M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More